New California Law Requires Pharmaceutical Companies to Adopt Compliance Program

About the Author
Mary Ellen Allen is an associate in the Los Angeles photo-1 office of Foley & Lardner LLP. She is a member of the Payments/Compliance Practice Group in the firm's Health Law Department. Ms. Allen's practice focuses on HIPAA privacy and clinical trials compliance. She has developed and implemented HIPAA privacy plans and now assists clients with HIPAA compliance efforts and privacy issues. She advises health care clients on the impact of HIPAA on research activities and negotiation of clinical research agreements.